BackElite Pharmaceuticals Overview

Elite Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for ELTP.

Quarterly Other Income/Expense

$11.82M
↑ 200.6% YoY

As of Dec 31, 2025

Annual Other Income/Expense (TTM)

$5.15M
↑ 117.46% YoY

Trailing 12 months ending Dec 31, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin